Pulse Biosciences (PLSE) Gains from Investment Securities (2015 - 2025)
Pulse Biosciences (PLSE) recorded quarterly Gains from Investment Securities of -$28000.0 in Q4 2025, down 102.33% quarter-over-quarter from $1.2 million in Q3 2025, and down 190.32% on a YoY basis from $31000.0 in Q4 2024.
Pulse Biosciences (PLSE) Gains from Investment Securities (2015 - 2025) Analysis & Trends
Pulse Biosciences' Gains from Investment Securities history runs 11 years deep, the most recent figure standing at -$28000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities fell 190.32% year-over-year to -$28000.0; the TTM figure through Dec 2025 stood at -$228000.0 (down 158.02% YoY), while the FY2025 annual figure was $2.3 million, down 79.01% from the prior year.
- Gains from Investment Securities was -$28000.0 for Q4 2025 at Pulse Biosciences, down from $1.2 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $9.5 million in Q4 2023 to a low of -$232000.0 in Q4 2021.
- Historically, Gains from Investment Securities has averaged $1.5 million across 5 years, with a median of $546222.0 in 2022.
- The sharpest annual moves came in 2021 and 2024: Gains from Investment Securities sank 2220.0% in 2021, then surged 4616.12% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$232000.0 in 2021, then jumped by 2138.96% to $4.7 million in 2022, then jumped by 100.11% to $9.5 million in 2023, then sank by 99.67% to $31000.0 in 2024, then sank by 190.32% to -$28000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$28000.0 (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28,000.00 |
| Dec 31, 2025 | -28,000.00 |
| Sep 30, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 855,000.00 |
| Sep 30, 2024 | 855,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 9.47 Mn |
| Dec 31, 2023 | 9.47 Mn |
| Sep 30, 2023 | 527,886.00 |
| Sep 30, 2023 | 527,886.00 |